This is going to be a universally used drug for bone mets -- nothing else works, and it reduces pain. In advanced metastatic cancer. FDA label doesn't matter. This old school -- get mets - get cabo: CRPC, Breast, etc.
Why does the label not matter - compendium listing, and QOL reduction of narcotics - why should terminal patients suffer....?
Approval coming early.